(Reuters) – The European regulator’s advisory panel on Thursday recommended authorizing Moderna’s COVID-19 vaccine targeting the Omicron XBB.1.5 subvariant. (Reporting by Leroy Leo in Bengaluru; Editing by Shinjini Ganguli)